Skip to content

Effect of dexmedetomidine in epidural labor analgesia on the blood glucose-coefficient of variation during delivery in patients with gestational diabetes mellitus

Effect of dexmedetomidine in epidural labor analgesia on the blood glucose coefficient of variation during childbirth in patients with gestational diabetes mellitus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080060
Enrollment
Unknown
Registered
2024-01-19
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

D group:dexmedetomidine+ ropivacaine
S group:sufentanil+ ropivacaine

Sponsors

Jinan Maternal and Child Health Hospital affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 20 and 40; (2) The 75g oral glucose tolerance test (OGTT) was accepted at 24-28 weeks of gestation, which met the diagnostic criteria for GDM of the International Association for the Study of Diabetes and Pregnancy; (3) gestational age =37 weeks; (4) Single fetus, head position; (5) pregnancy, childbirth and postpartum did not use insulin, metformin and other hypoglycemic drugs; (6) Vaginal delivery; (7) no spinal anesthesia contraindications, voluntary labor analgesia after regular contractions; (8) Agree to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Uterine opening to more than 4cm; (2) severe systemic diseases of liver, kidney, heart, lung, etc.; (3) bradycardia, arrhythmia; (4) long-term use of sedatives or analgesics; (5) People with abnormal spirits

Design outcomes

Primary

MeasureTime frame
plasma glucose-coefficient of variation;

Countries

China

Contacts

Public ContactYanan Liang

Jinan Maternal and Child Health Hospital affiliated to Shandong First Medical University

398287069@qq.com+86 180 5315 9031

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026